Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Multicenter, Phase IV, Study Evaluating RELiZORB Use for the Treatment of Feeding Intolerance in Adults With Moderate to Severe Acute Pancreatitis

NCT07583342 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT07583342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07583342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Multicenter, Phase IV, Study Evaluating RELiZORB Use for the Treatment of Feeding Intolerance in Adults With Moderate to Severe Acute Pancreatitis
Lead sponsor
Northwell Health
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
December 8, 2025
Completion date
December 31, 2026
Enrollment
15 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute pancreatitis (ap), enhancing enteral nutrition tolerance